April 1, 2021Open Access
View Full PaperAssessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability–High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
Key Points
Key points are not available for this paper at this time.
Abstract
ClinicalTrials.gov Identifiers: NCT02335411, NCT02370498, and NCT02494583.